Journal Information
Vol. 33. Issue 7 - 8.
Pages 487 (July - August 2014)
Share
Share
Download PDF
More article options
Vol. 33. Issue 7 - 8.
Pages 487 (July - August 2014)
Letter to the Editor
Open Access
Cardiac magnetic resonance imaging in cardiomyopathies that look alike
Ressonância magnética cardíaca nuclear em miocardiopatias parecidas
Visits
5099
Emre Yalcinkayaa,
Corresponding author
dremreyalcinkaya@gmail.com

Corresponding author.
, Murat Celikb
a Aksaz Military Hospital, Department of Cardiology, Mugla, Turkey
b Gulhane Military Medical Faculty, Department of Cardiology, Ankara, Turkey
Related content
Dinis Mesquita, Carla Nobre, Boban Thomas, Nuno Jalles Tavares
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
To the Editor,

We read with great interest the article by Mesquita et al.1 entitled “Cardiac amyloidosis: Diagnosis using delayed enhancement cardiac magnetic resonance imaging sequences”, recently published in the Portuguese Journal of Cardiology. The authors1 presented 10 patients with the suspicion of a cardiomyopathy on echocardiography. Patients were diagnosed and managed with late gadolinium enhancement patterns on cardiac magnetic resonance (MR) imaging. Although we commend the authors for their valuable article and the management of the patients, some comments may be of interest.

Cardiac amyloidosis is characterized by diffuse global subendothelial late gadolinium enhancement.2,3 Increased gadolinium washout from blood results in higher blood T1 over time, resulting in a dark blood pool, which does not occur in other cardiomyopathies.2,4 If cardiac wall thickness is increased, a decrease in QRS amplitude associated with dyssynchronous activation of atrophic myocytes is an important finding.2,3

Fabry disease is characterized by symmetrical hypertrophy, and men are commonly affected due to X-linked inheritance. Progressive diastolic dysfunction is generally observed without a restrictive filling pattern on echocardiography.2

Hypertrophic cardiomyopathy is characterized by asymmetrical hypertrophy which can result in ventricular outflow obstruction.2 Although cardiac myocytes are hypertrophic, they do not contribute significantly to effective contraction. Tagged MR images can show the disordered and ineffective contraction patterns in cardiomyopathies accompanied by septal hypertrophy, thereby distinguishing hypertensive cardiomyopathy.2

In conclusion, cardiomyopathies accompanied by increased wall thickness are characterized by impeded ventricular filling and progressive diastolic dysfunction.2–4 They are relatively rare and usually tend to be overlooked or misdiagnosed. Comprehensive assessment of patients, including clinical manifestations, electrocardiography, and echocardiography in addition to MR imaging, play an important role in instituting appropriate management and therapy.5

References
[1]
D. Mesquita, C. Nobre, B. Thomas, et al.
Cardiac amyloidosis: diagnosis using delayed enhancement cardiac magnetic resonance imaging sequences.
Rev Port Cardiol, 32 (2013), pp. 941-945
[2]
J.B. Seward, G. Casaclang-Verzosa.
Infiltrative cardiovascular diseases: cardiomyopathies that look alike.
J Am Coll Cardiol, 55 (2010), pp. 1769-1779
[3]
M. Oliveira Santos, D. Brito.
Severe heart disease in an unusual case of familial amyloid polyneuropathy type I.
Rev Port Cardiol, 32 (2013), pp. 729-733
[4]
A.M. Maceira, J. Joshi, S.K. Prasad, et al.
Cardiovascular magnetic resonance in cardiac amyloidosis.
Circulation, 111 (2005), pp. 186-193
[5]
E. Yalçınkaya, B. Bugan, M. Celik, et al.
Differential diagnosis of cardiomyopathies: utility of cardiac magnetic resonance imaging.
Anadolu Kardiyol Derg, 13 (2013), pp. 722
Copyright © 2014. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.